EAGLE ASSET MANAGEMENT INC - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 84 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2020$14,357,000
-46.2%
1,687,143
+4.1%
0.09%
-30.5%
Q4 2019$26,703,000
+15.7%
1,621,365
-0.8%
0.13%
+7.6%
Q3 2019$23,088,000
-28.4%
1,635,140
+1.9%
0.12%
-27.9%
Q2 2019$32,265,000
-47.4%
1,604,452
+4.1%
0.16%
-49.5%
Q1 2019$61,285,000
+9.6%
1,541,762
-4.2%
0.33%
-7.1%
Q4 2018$55,921,000
-16.8%
1,609,712
-0.9%
0.35%
+8.3%
Q3 2018$67,192,000
+25.2%
1,624,958
+11.2%
0.32%
+12.5%
Q2 2018$53,682,000
-7.4%
1,460,739
-1.7%
0.29%
-8.3%
Q1 2018$57,976,000
+101.9%
1,486,567
-0.0%
0.32%
+99.4%
Q4 2017$28,712,000
+11.4%
1,486,844
-0.2%
0.16%
+6.8%
Q3 2017$25,778,000
+23.3%
1,490,076
-0.2%
0.15%
+17.5%
Q2 2017$20,901,000
-19.8%
1,492,976
+17.8%
0.13%
-23.2%
Q1 2017$26,049,000
+65.2%
1,267,609
+14.1%
0.16%
+57.7%
Q4 2016$15,771,000
-24.8%
1,110,698
+13.3%
0.10%
-26.8%
Q3 2016$20,976,000
-4.2%
980,673
+0.8%
0.14%
-6.6%
Q2 2016$21,893,000
+12.1%
972,592
-5.2%
0.15%
+11.8%
Q1 2016$19,524,000
-13.4%
1,025,988
+20.2%
0.14%
-9.9%
Q4 2015$22,538,000
-36.3%
853,400
-24.1%
0.15%
+24.8%
Q3 2015$35,364,0001,124,8640.12%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
BRIDGER MANAGEMENT, LLC 2,932,865$48,304,0003.48%
Camber Capital Management LP 2,950,000$48,587,0002.47%
Trellus Management Company, LLC 87,873$1,447,0002.42%
Redmile Group, LLC 4,648,570$76,562,0001.83%
Baupost Group 8,308,900$136,848,0001.51%
MAVERICK CAPITAL LTD 4,958,431$81,665,0001.19%
Artal Group S.A. 1,750,000$28,823,0001.11%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 175,000$2,882,0000.36%
12 West Capital Management LP 158,700$2,614,0000.16%
WASATCH ADVISORS LP 1,101,103$18,135,0000.15%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders